1. Home
  2. ZBAI vs EVOK Comparison

ZBAI vs EVOK Comparison

Compare ZBAI & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBAI
  • EVOK
  • Stock Information
  • Founded
  • ZBAI 2015
  • EVOK 2007
  • Country
  • ZBAI United States
  • EVOK United States
  • Employees
  • ZBAI N/A
  • EVOK N/A
  • Industry
  • ZBAI Professional Services
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZBAI Consumer Discretionary
  • EVOK Health Care
  • Exchange
  • ZBAI Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • ZBAI 6.5M
  • EVOK 5.4M
  • IPO Year
  • ZBAI N/A
  • EVOK 2013
  • Fundamental
  • Price
  • ZBAI $5.75
  • EVOK $5.12
  • Analyst Decision
  • ZBAI
  • EVOK
  • Analyst Count
  • ZBAI 0
  • EVOK 0
  • Target Price
  • ZBAI N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • ZBAI 35.0K
  • EVOK 104.5K
  • Earning Date
  • ZBAI 06-06-2025
  • EVOK 08-14-2025
  • Dividend Yield
  • ZBAI N/A
  • EVOK N/A
  • EPS Growth
  • ZBAI N/A
  • EVOK N/A
  • EPS
  • ZBAI N/A
  • EVOK N/A
  • Revenue
  • ZBAI $720,000.00
  • EVOK $12,794,859.00
  • Revenue This Year
  • ZBAI N/A
  • EVOK $57.82
  • Revenue Next Year
  • ZBAI N/A
  • EVOK $59.12
  • P/E Ratio
  • ZBAI N/A
  • EVOK N/A
  • Revenue Growth
  • ZBAI 44.00
  • EVOK 70.02
  • 52 Week Low
  • ZBAI $4.93
  • EVOK $1.94
  • 52 Week High
  • ZBAI $45.00
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • ZBAI N/A
  • EVOK 55.77
  • Support Level
  • ZBAI N/A
  • EVOK $4.61
  • Resistance Level
  • ZBAI N/A
  • EVOK $5.70
  • Average True Range (ATR)
  • ZBAI 0.00
  • EVOK 0.52
  • MACD
  • ZBAI 0.00
  • EVOK -0.03
  • Stochastic Oscillator
  • ZBAI 0.00
  • EVOK 71.01

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: